Exeliom Biosciences (private company)
See something wrong or missing? Let us know
Offices:Dijon
Industry:BiotechHealth services
Business model:B2B
Exeliom Biosciences is a clinical-stage biopharmaceutical company from France specialized in the development of microbiome-based immunotherapies with a mission to bring innovation to the treatment of inflammatory bowel diseases, cancer, and infectious diseases
Investors:
we tracked 5 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 23.75M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Exeliom Biosciences
| Name | Criteria | |
|---|---|---|
![]() |
AbolerIS Pharma
53%
|
|
![]() |
Acesion Pharma
53%
|
|
![]() |
Achilles Therapeutics
53%
|
|
![]() |
Antag Therapeutics
53%
|
|
![]() |
Aprea Therapeutics
53%
|
|
![]() |
Arthex Biotech S.L.
53%
|
|
![]() |
Atai Life Sciences
53%
|
|
![]() |
Biofidelity
53%
|
|
![]() |
BoneSupport
53%
|
|
![]() |
CatalYm
53%
|
|






Belgium
Netherlands
Austria
Switzerland
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Ireland
Italy
Portugal